Clinical pharmacokinetics and potentially important drug interactions of sulphinpyrazone

Reactive oxygen species alter dopaminergic and purinergic signaling and microglia physiology in the nucleus accumbens.

bioRxiv : the preprint server for biology·2026

Improved quality of life with semaglutide in schizophrenia: Secondary analyses from a randomized controlled trial.

Schizophrenia research·2026

The association between migraine and dementia - a national register-based matched cohort study.

Public health·2022

Validation of the Danish versions of the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaires (BRAFs).

Scandinavian journal of rheumatology·2021

More precise phenotyping of cluster headache using prospective attack reports.

European journal of neurology·2019

Identification of New Sources of Resistance in Winter Wheat to Multiple Strains of Xanthomonas translucens pv. undulosa.

Plant disease·2019

Comparing the Predictive Performance of Machine Learning Models with a Newly Developed Population Pharmacokinetic Model for Busulfan in Paediatric Patients.

Clinical pharmacokinetics·2026

PBPK Modeling of Coproporphyrin I Reveals Frailty-Associated Changes in Hepatic OATP1B1 Function in Chinese Adults.

Clinical pharmacokinetics·2026

Clinical Pharmacokinetics and Disposition of Imrecoxib.

Clinical pharmacokinetics·2026

Towards Model-Informed Precision Dosing of High-Dose Rifampicin: A Parsimonious Population Pharmacokinetic Model Capturing Saturation and Autoinduction in Tanzanian and South African Patients with Tuberculosis.

Clinical pharmacokinetics·2026

From Clinical Trials to Real-World Patients: Population Pharmacokinetics and Precision Dosing Simulations of Lorlatinib.

Clinical pharmacokinetics·2026

Clinical Pharmacokinetics and Pharmacodynamics of Marstacimab, an Anti-tissue Factor Pathway Inhibitor Monoclonal Antibody, in Adolescent and Adult Participants with Hemophilia.

Clinical pharmacokinetics·2026

A review of FDG-PET biomarker analysis methods in Parkinson's disease.

Journal of Parkinson's disease·2026

Comparative real-world safety profiles of selective β1-adrenergic receptor blockers: A multi-database pharmacovigilance disproportionality study.

Medicine·2026

The Impact of Polycyclic Aromatic Hydrocarbons Exposure from Seasonal Biomass Burning on Oxidative Stress and Genotoxicity Biomarkers in Patients with Diabetes and Hypertension in Chiang Mai, Thailand.

Toxics·2026

New-Onset Pemphigus Following Drug Exposure and Vaccination: A Systematic Review of Reported Cases.

Vaccines·2026

Mapping Pharmacogenomic Determinants of Adverse Drug Reactions in Hypertension: A Systematic Review.

Pharmaceuticals (Basel, Switzerland)·2026

Development and Evaluation of Physiologically Based Pharmacokinetic (PBPK) Models of Metoclopramide Across the Lifespan: Translation from Adults to Infants.

Pharmaceuticals (Basel, Switzerland)·2026

Related Experiment Videos

Clinical pharmacokinetics and potentially important drug interactions of sulphinpyrazone

Related Concept Videos

Reactive oxygen species alter dopaminergic and purinergic signaling and microglia physiology in the nucleus accumbens.

Improved quality of life with semaglutide in schizophrenia: Secondary analyses from a randomized controlled trial.

The association between migraine and dementia - a national register-based matched cohort study.

Validation of the Danish versions of the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaires (BRAFs).

More precise phenotyping of cluster headache using prospective attack reports.

Identification of New Sources of Resistance in Winter Wheat to Multiple Strains of Xanthomonas translucens pv. undulosa.

Comparing the Predictive Performance of Machine Learning Models with a Newly Developed Population Pharmacokinetic Model for Busulfan in Paediatric Patients.

PBPK Modeling of Coproporphyrin I Reveals Frailty-Associated Changes in Hepatic OATP1B1 Function in Chinese Adults.

Clinical Pharmacokinetics and Disposition of Imrecoxib.

Towards Model-Informed Precision Dosing of High-Dose Rifampicin: A Parsimonious Population Pharmacokinetic Model Capturing Saturation and Autoinduction in Tanzanian and South African Patients with Tuberculosis.

From Clinical Trials to Real-World Patients: Population Pharmacokinetics and Precision Dosing Simulations of Lorlatinib.

Clinical Pharmacokinetics and Pharmacodynamics of Marstacimab, an Anti-tissue Factor Pathway Inhibitor Monoclonal Antibody, in Adolescent and Adult Participants with Hemophilia.

A review of FDG-PET biomarker analysis methods in Parkinson's disease.

Comparative real-world safety profiles of selective β1-adrenergic receptor blockers: A multi-database pharmacovigilance disproportionality study.

The Impact of Polycyclic Aromatic Hydrocarbons Exposure from Seasonal Biomass Burning on Oxidative Stress and Genotoxicity Biomarkers in Patients with Diabetes and Hypertension in Chiang Mai, Thailand.

New-Onset Pemphigus Following Drug Exposure and Vaccination: A Systematic Review of Reported Cases.

Mapping Pharmacogenomic Determinants of Adverse Drug Reactions in Hypertension: A Systematic Review.

Development and Evaluation of Physiologically Based Pharmacokinetic (PBPK) Models of Metoclopramide Across the Lifespan: Translation from Adults to Infants.

Related Experiment Videos

Clinical pharmacokinetics and potentially important drug interactions of sulphinpyrazone

Related Concept Videos

Related Articles